No black box warning on record for Homatropine Hydrobromide Ophthalmic

As of the latest FDA labeling reviewed, Homatropine Hydrobromide Ophthalmic (HOMATROPINE HYDROBROMIDE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Homatropine Hydrobromide Ophthalmic medicine page for the complete safety profile.

Other warnings & precautions

WARNING: For topical use only – not for injection. Risk-benefit should be considered when the following medical problems exist: keratoconus (Homatropine may produce fixed dilated pupil); Down’s syndrome, children with brain damage and the elderly (increased susceptibility). In infants and small children, use with extreme caution. Excessive use in pediatric patients or certain individuals with a hi

No black box warning on record for Homatropine Hydrobromide Ophthalmic

Other warnings & precautions

WARNING: For topical use only – not for injection. Risk-benefit should be considered when the following medical problems exist: keratoconus (Homatropine may produce fixed dilated pupil); Down’s syndrome, children with brain damage and the elderly (increased susceptibility). In infants and small children, use with extreme caution. Excessive use in pediatric patients or certain individuals with a hi

Homatropine Hydrobromide Ophthalmic Black Box Warning

No black box warning on record for Homatropine Hydrobromide Ophthalmic

Other warnings & precautions

Homatropine Hydrobromide Ophthalmic Black Box Warning

No black box warning on record for Homatropine Hydrobromide Ophthalmic

Other warnings & precautions